These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15780611)

  • 1. Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.
    Blagg JA; Noe MC; Wolf-Gouveia LA; Reiter LA; Laird ER; Chang SP; Danley DE; Downs JT; Elliott NC; Eskra JD; Griffiths RJ; Hardink JR; Haugeto AI; Jones CS; Liras JL; Lopresti-Morrow LL; Mitchell PG; Pandit J; Robinson RP; Subramanyam C; Vaughn-Bowser ML; Yocum SA
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1807-10. PubMed ID: 15780611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.
    Freeman-Cook KD; Reiter LA; Noe MC; Antipas AS; Danley DE; Datta K; Downs JT; Eisenbeis S; Eskra JD; Garmene DJ; Greer EM; Griffiths RJ; Guzman R; Hardink JR; Janat F; Jones CS; Martinelli GJ; Mitchell PG; Laird ER; Liras JL; Lopresti-Morrow LL; Pandit J; Reilly UD; Robertson D; Vaughn-Bowser ML; Wolf-Gouviea LA; Yocum SA
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6529-34. PubMed ID: 17935984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
    Noe MC; Natarajan V; Snow SL; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Carty TJ; Barberia JA; Sweeney FJ; Liras JL; Vaughn M; Hardink JR; Hawkins JM; Tokar C
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2808-11. PubMed ID: 15911259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
    Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent and selective MMP-13 inhibitors.
    Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).
    Graf von Roedern E; Grams F; Brandstetter H; Moroder L
    J Med Chem; 1998 Jan; 41(3):339-45. PubMed ID: 9464365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
    Cherney RJ; Mo R; Meyer DT; Hardman KD; Liu RQ; Covington MB; Qian M; Wasserman ZR; Christ DD; Trzaskos JM; Newton RC; Decicco CP
    J Med Chem; 2004 Jun; 47(12):2981-3. PubMed ID: 15163180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
    Noe MC; Natarajan V; Snow SL; Wolf-Gouveia LA; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Otterness I; Bliven MA; Carty TJ; Barberia JT; Sweeney FJ; Liras JL; Vaughn M
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3385-8. PubMed ID: 15953722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
    Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent, selective pyrimidinetrione-based inhibitors of MMP-13.
    Reiter LA; Freeman-Cook KD; Jones CS; Martinelli GJ; Antipas AS; Berliner MA; Datta K; Downs JT; Eskra JD; Forman MD; Greer EM; Guzman R; Hardink JR; Janat F; Keene NF; Laird ER; Liras JL; Lopresti-Morrow LL; Mitchell PG; Pandit J; Robertson D; Sperger D; Vaughn-Bowser ML; Waller DM; Yocum SA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5822-6. PubMed ID: 16942871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.
    Brandstetter H; Engh RA; Von Roedern EG; Moroder L; Huber R; Bode W; Grams F
    Protein Sci; 1998 Jun; 7(6):1303-9. PubMed ID: 9655333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).
    Kim SH; Pudzianowski AT; Leavitt KJ; Barbosa J; McDonnell PA; Metzler WJ; Rankin BM; Liu R; Vaccaro W; Pitts W
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1101-6. PubMed ID: 15686921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).
    Graf von Roedern E; Brandstetter H; Engh RA; Bode W; Grams F; Moroder L
    J Med Chem; 1998 Jul; 41(16):3041-7. PubMed ID: 9685244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
    Stoll V; Stewart KD; Maring CJ; Muchmore S; Giranda V; Gu YG; Wang G; Chen Y; Sun M; Zhao C; Kennedy AL; Madigan DL; Xu Y; Saldivar A; Kati W; Laver G; Sowin T; Sham HL; Greer J; Kempf D
    Biochemistry; 2003 Jan; 42(3):718-27. PubMed ID: 12534284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: Synthesis and SAR studies.
    Liu M; Wang S; Clampit JE; Gum RJ; Haasch DL; Rondinone CM; Trevillyan JM; Abad-Zapatero C; Fry EH; Sham HL; Liu G
    Bioorg Med Chem Lett; 2007 Feb; 17(3):668-72. PubMed ID: 17107797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization.
    Sanders WJ; Nienaber VL; Lerner CG; McCall JO; Merrick SM; Swanson SJ; Harlan JE; Stoll VS; Stamper GF; Betz SF; Condroski KR; Meadows RP; Severin JM; Walter KA; Magdalinos P; Jakob CG; Wagner R; Beutel BA
    J Med Chem; 2004 Mar; 47(7):1709-18. PubMed ID: 15027862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
    Hu Y; Xiang JS; DiGrandi MJ; Du X; Ipek M; Laakso LM; Li J; Li W; Rush TS; Schmid J; Skotnicki JS; Tam S; Thomason JR; Wang Q; Levin JI
    Bioorg Med Chem; 2005 Dec; 13(24):6629-44. PubMed ID: 16216515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.